Rajangam Kanya 4

What Happened
Rajangam Kanya, President and Chief Medical & Development Officer of Senti Biosciences, had 1,384 shares of common stock withheld by the company on Feb 2, 2026 to satisfy tax withholding related to the net settlement of time‑based restricted stock units (RSUs). The filing reports these shares as disposed at a price of $0.00 (total reported value $0) — this reflects withholding, not a cash sale.

Key Details

• Transaction date: 2026-02-02 (reported on Form 4 filed 2026-02-03).
• Transaction code: F — payment of exercise price or tax liability (tax‑withholding on vesting).
• Shares withheld/disposed: 1,384; reported price $0.00; total value reported $0.
• Footnote: Issuer withheld shares to satisfy income tax withholding for net‑settled time‑based RSUs; this is not an open‑market sale (F1).
• Shares owned after the transaction: not specified in the provided excerpt.
• Timeliness: Filing appears timely (filed the next day).

Context
Withholding shares to cover taxes on vested RSUs is a routine administrative action and does not indicate an insider selling shares on the open market. Purchases or open‑market sales are generally more informative about insider sentiment than tax‑withholding events.